![Gordon Brooks](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Gordon J.
Brooks currently works at Dermira, Inc., as Director from 2020, ARMO BioSciences, Inc., as Director from 2018, and Sigilon Therapeutics, Inc., as Director from 2023.
Aktive Positionen von Gordon Brooks
| Unternehmen | Position | Beginn |
|---|---|---|
| ARMO BIOSCIENCES INC | Direktor/Vorstandsmitglied | 21.06.2018 |
| DERMIRA, INC. | Direktor/Vorstandsmitglied | 20.02.2020 |
| SIGILON THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 11.08.2023 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
48
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
